Early pembrolizumab as salvage therapy in EMA-CO-refractory ultra-high-risk gestational choriocarcinoma. // Seminars in Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S0093775426001156?dgcid=rss_sd_all
Early pembrolizumab as salvage therapy in EMA-CO-refractory ultra-high-risk gestational choriocarcinoma. Seminars in Oncology. https://www.sciencedirect.com/science/article/pii/S0093775426001156?dgcid=rss_sd_all
“Early pembrolizumab as salvage therapy in EMA-CO-refractory ultra-high-risk gestational choriocarcinoma.” Seminars in Oncology.
@article{article65792,
title = {Early pembrolizumab as salvage therapy in EMA-CO-refractory ultra-high-risk gestational choriocarcinoma},
journal = {Seminars in Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S0093775426001156?dgcid=rss_sd_all}
}